WS Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-26,646
| Closed | -$812K | – | 47 |
|
2023
Q4 | $812K | Hold |
26,646
| – | – | 0.05% | 39 |
|
2023
Q3 | $843K | Hold |
26,646
| – | – | 0.07% | 38 |
|
2023
Q2 | $1.09M | Hold |
26,646
| – | – | 0.09% | 35 |
|
2023
Q1 | $993K | Hold |
26,646
| – | – | 0.11% | 36 |
|
2022
Q4 | $930K | Hold |
26,646
| – | – | 0.08% | 38 |
|
2022
Q3 | $1.49M | Hold |
26,646
| – | – | 0.14% | 33 |
|
2022
Q2 | $1.38M | Hold |
26,646
| – | – | 0.11% | 39 |
|
2022
Q1 | $1.94M | Hold |
26,646
| – | – | 0.09% | 40 |
|
2021
Q4 | $3.15M | Hold |
26,646
| – | – | 0.25% | 35 |
|
2021
Q3 | $3.58M | Hold |
26,646
| – | – | 0.38% | 35 |
|
2021
Q2 | $4.31M | Sell |
26,646
-13,323
| -33% | -$2.16M | 0.43% | 36 |
|
2021
Q1 | $3.21M | Sell |
39,969
-2,049
| -5% | -$164K | 0.33% | 35 |
|
2020
Q4 | $2.29M | Hold |
42,018
| – | – | 0.24% | 34 |
|
2020
Q3 | $835K | Hold |
42,018
| – | – | 0.09% | 47 |
|
2020
Q2 | $883K | Sell |
42,018
-7,212
| -15% | -$152K | 0.11% | 44 |
|
2020
Q1 | $602K | Sell |
49,230
-2,470
| -5% | -$30.2K | 0.07% | 49 |
|
2019
Q4 | $758K | Hold |
51,700
| – | – | 0.06% | 48 |
|
2019
Q3 | $690K | Sell |
51,700
-5,692
| -10% | -$76K | 0.05% | 49 |
|
2019
Q2 | $940K | Sell |
57,392
-6,776
| -11% | -$111K | 0.06% | 52 |
|
2019
Q1 | $1.1M | Sell |
64,168
-8,630
| -12% | -$147K | 0.07% | 53 |
|
2018
Q4 | $994K | Sell |
72,798
-47,202
| -39% | -$645K | 0.05% | 66 |
|
2018
Q3 | $3.43M | Hold |
120,000
| – | – | 0.11% | 64 |
|
2018
Q2 | $3.28M | Buy |
+120,000
| New | +$3.28M | 0.09% | 61 |
|